4//SEC Filing
Lennon David James 4
Accession 0001415889-25-010076
CIK 0001422142other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 7:22 PM ET
Size
8.9 KB
Accession
0001415889-25-010076
Insider Transaction Report
Form 4
Lennon David James
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Award
Stock Option (right to buy)
2025-04-01+775,828→ 775,828 totalExercise: $1.70Exp: 2035-04-01→ Common Stock (775,828 underlying) - Award
Restricted Stock Units
2025-04-01+775,828→ 775,828 total→ Common Stock (775,828 underlying)
Footnotes (3)
- [F1]Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the Option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean April 1, 2025.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock.
- [F3]Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one hundred percent (100%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean April 1, 2025.
Documents
Issuer
Whitehawk Therapeutics, Inc.
CIK 0001422142
Entity typeother
Related Parties
1- filerCIK 0001995275
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 7:22 PM ET
- Size
- 8.9 KB